Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-22-014951

President & CEO sold 832 shares at $56.10 ($46,675)

  • President & CEO acquired 26,041 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Simon, Christopher · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-16 Sale : show line 1 in the form −832 $56.10 $46,675 191,327 D
2022-05-16 Grant or award : show line 2 in the form +26,041 217,368 D
Open-market sales · 832 sh · avg $56.10 · $46,675

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-05-16 Grant or award : show line 3 in the form Non-qualified Stock Option (Right to Buy) +60,891 60,891 D
Loading xslF345X03/form4.xml…